OTCMKTS:SONVY

Sonova Stock Forecast, Price & News

$51.51

-0.12 (-0.23 %)

(As of 01/21/2021 12:00 AM ET)

Add

Compare

Today's Range

$51.17

Now: $51.51▼

$51.54

50-Day Range

$49.22

MA: $50.83▼

$52.68

52-Week Range

$29.41

Now: $51.51▼

$54.77

Volume15,892 shs

Average Volume17,635 shs

Market Capitalization$16.59 billion

P/E Ratio34.57

Dividend YieldN/A

Beta0.7

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It operates through two segments, Hearing Instruments and Cochlear Implants segments. It offers wireless communication products, rechargeable hearing aids, and professional audiological care services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; and professional hearing care services under the AudioNova, Audium, AuditionSantÃ©, Boots Hearingcare, Connect Hearing, Fiebing, Geers, Hansaton, Lapperre, Lindacher, Schoonenberg, Triton, and Vitakustik brands. Sonova Holding AG sells its products through wholesale companies and independent distributors; and provides professional audiological care services through a network of approximately 3,500 stores and clinics. It operates in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in StÃ¤fa, Switzerland.

MarketRank^™

Overall MarketRank^™

0.90 out of 5 stars

Medical Sector

1045th out of 1,926 stocks

Electromedical Equipment Industry

30th out of 61 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Sonova.

2.0 Community Rank

Outperform Votes
Sonova has received 121 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Sonova has received 189 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Sonova has received 60.97% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Sonova and other stocks. Vote “Outperform” if you believe SONVY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SONVY will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Sonova does not currently pay a dividend.
Dividend Growth
Sonova does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sonova insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 1.12% of the stock of Sonova is held by institutions.

2.5 Earnings and Valuation

Earnings Growth
Earnings for Sonova are expected to grow by 38.78% in the coming year, from $1.47 to $2.04 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Sonova is 34.57, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.56.
Price to Earnings Ratio vs. Sector
The P/E ratio of Sonova is 34.57, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 35.83.
Price to Book Value per Share Ratio
Sonova has a P/B Ratio of 8.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Electromedical equipment

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:SONVY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.sonova.com

Phone41-58-928-3333

Employees15,184

Debt

Debt-to-Equity Ratio0.69

Current Ratio2.57

Quick Ratio2.26

Price-To-Earnings

Trailing P/E Ratio34.57

Forward P/E Ratio35.04

P/E GrowthN/A

Sales & Book Value

Annual Sales$2.96 billion

Price / Sales5.61

Cash Flow$2.15 per share

Price / Cash Flow23.93

Book Value$6.35 per share

Price / Book8.11

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares321,991,000

Market Cap$16.59 billion

Next Earnings DateN/A

OptionableNot Optionable

$51.51

-0.12 (-0.23 %)

(As of 01/21/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive SONVY News and Ratings via Email

Sign-up to receive the latest news and ratings for SONVY and its competitors with MarketBeat's FREE daily newsletter.

Sonova (OTCMKTS:SONVY) Frequently Asked Questions

How has Sonova's stock been impacted by Coronavirus (COVID-19)?

Sonova's stock was trading at $44.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SONVY shares have increased by 16.5% and is now trading at $51.51.
View which stocks have been most impacted by COVID-19.

Is Sonova a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sonova in the last year. There are currently 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Sonova stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SONVY, but not buy additional shares or sell existing shares.
View analyst ratings for Sonova or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Sonova?

Wall Street analysts have given Sonova a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sonova wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sonova?

Sonova saw a decrease in short interest in the month of December. As of December 31st, there was short interest totaling 5,800 shares, a decrease of 20.5% from the December 15th total of 7,300 shares. Based on an average trading volume of 27,100 shares, the short-interest ratio is currently 0.2 days.
View Sonova's Short Interest.

Who are some of Sonova's key competitors?

Some companies that are related to Sonova include Varian Medical Systems (VAR), Masimo (MASI), Getinge (GNGBY), CONMED (CNMD), LivaNova (LIVN), Outset Medical (OM), InMode (INMD), BioLife Solutions (BLFS), Natus Medical (NTUS), ViewRay (VRAY), AxoGen (AXGN), TransMedics Group (TMDX), Semler Scientific (SMLR), Zynex (ZYXI) and Cutera (CUTR).
View all of SONVY's competitors.

Who are Sonova's key executives?

Sonova's management team includes the following people:

Mr. Arnd Kaldowski, CEO, COO & Member of Management Board (Age 54)
Dr. Hartwig Grevener, CFO & Member of Management Board (Age 55)
Mr. Andi Vonlanthen, Group VP of R&D and Member of Management Board (Age 60)
Mr. Claude Diversi, Group VP of Hearing Instruments Wholesale & Member of Management Board (Age 57)
Mr. Martin Grieder, Group VP of Hearing Instruments Marketing & Member of Management Board (Age 56)
Mr. Christophe Fond, Group VP of Audiological Care & Member of Management Board (Age 55)
Mr. Claudio Bartesaghi, Group VP of Corp. HRM & Communications and Member of Management Board (Age 48)
Dr. Victoria E. Carr-Brendel, Member of Management Board, Group VP of Cochlear Implants & Pres of Advanced Bionics (Age 57)
Mr. Ludger Althoff, Group VP of Operations & Member of Management Board (Age 57)
Mr. Thomas BernhardsgrÃ¼tter, Director of Investor Relations

What is Sonova's stock symbol?

Sonova trades on the OTCMKTS under the ticker symbol "SONVY."

How do I buy shares of Sonova?

Shares of SONVY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sonova's stock price today?

One share of SONVY stock can currently be purchased for approximately $51.51.

How big of a company is Sonova?

Sonova has a market capitalization of $16.59 billion and generates $2.96 billion in revenue each year. The company earns $489.96 million in net income (profit) each year or $1.49 on an earnings per share basis. Sonova employs 15,184 workers across the globe.

What is Sonova's official website?

The official website for Sonova is www.sonova.com.

How can I contact Sonova?

Sonova's mailing address is Laubisrutistrasse 28, Stafa V8, 8712. The company can be reached via phone at 41-58-928-3333 or via email at [email protected]

This page was last updated on 1/22/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here